drugset

drugset / Trial / NCT00484328

Ribavirin, Its Dosing Regime

NCT00484328 ↗

Phase 4 Completed 15 enrolled Maastricht University Medical Center Roche Pharma AG · collab

RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of this study is to determine if the medicines for chronic hepatitis C can be taken once daily, instead of twice daily.

Timeline

Start: 2007-07
Primary completion: 2012-12
Completion: 2012-12

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Ribavirin	Small molecule	—	—

Indications